Belgium - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Belgium Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 7.2% year on year. In 2019, the country was ranked number 229 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 17 Cases. India topped the ranking with 66,255 Cases in 2019, that is a growth of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.

Loading...

Date Units (Cases)
2019 17.00
2018 9.00
2017 8.00
2016 12.00
2015 17.00
Download all data from 2005 to 2019

How does Belgium rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
229 #229
Austria
17 2019 +0.0 % -19.4 % View data
229 #229
Belgium
17 2019 +88.9 % +7.2 % View data
229 #229
Sweden
17 2019 +6.3 % -1.1 % View data
Compare all 359 countries

Go Top